BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6136075)

  • 1. [Serum zinc and copper in patients with atherosclerosis obliterans of the lower limbs].
    Uza C; Kovacs A; Vlaicu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(6):509-13. PubMed ID: 6136075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term correlations of selected trace elements and lipid parameters in arteriosclerosis obliterans].
    Reuter W; Voigt H; Peters HJ; Vorberg B
    Vasa Suppl; 1991; 33():155. PubMed ID: 1788653
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum zinc and copper in patients with thromboangiitis obliterans of the lower limbs].
    Uza G; Kovacs A; Pitea P; Vedean A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(3):285-8. PubMed ID: 2876483
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte deformability in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H; Rość D; Chyzy R; Szpak A
    Acta Med Pol; 1983; 24(1-4):55-63. PubMed ID: 6679687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood coagulation in arteriosclerosis obliterans of the lower limbs].
    Chubar' SV
    Vrach Delo; 1978 Oct; (10):21-5. PubMed ID: 716352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the clotting system and fibrinolysis after 1-stage novocaine parasciatic blockade in patients with obliterating atherosclerosis of the lower limbs].
    Kempf Z
    Przegl Lek; 1970 Sep; 26(9):735-7. PubMed ID: 5472570
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid metabolism indices of patients with arteriosclerosis obliterans of the lower extremities].
    Satmari VV; Kucher VN; Portugal' AS; Gribenko VV
    Vrach Delo; 1984 Feb; (2):70-1. PubMed ID: 6719877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical importance of the regional study of blood serum lipids in arteriosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Kontorshchikova KN; Parakhoniak NV
    Patol Fiziol Eksp Ter; 1986; (2):23-5. PubMed ID: 3714313
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood basocytes in obliterative arteriosclerosis of lower limbs].
    Gonciarz Z
    Pol Tyg Lek; 1967 Sep; 22(39):1480-2. PubMed ID: 6082508
    [No Abstract]   [Full Text] [Related]  

  • 11. [HDL fractions in men with coronary disease and arteriosclerosis obliterans of the lower limbs with normal plasma lipid levels].
    Sznajderman M; Kancelarczyk WL; Rymaszewski Z; Mamont B
    Kardiol Pol; 1983; 26(8-9):623-8. PubMed ID: 6663975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indices of thrombocytic activity in patients with obliterating atherosclerosis of the arteries of the lower extremities].
    Iakunin GA; Kurguzov OP; Lavrova LA; Novikova AN
    Lab Delo; 1990; (3):77-8. PubMed ID: 1692921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium, magnesium, copper and zinc in blood serum in men with femoral atherosclerosis].
    Mielcarz G; Majewski W; Patelski J; Uryszek W
    Rocz Panstw Zakl Hig; 1995; 46(1):59-65. PubMed ID: 7481505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HDL lipids in men with obliterating atherosclerosis of the lower extremities (author's transl)].
    Zák A; Zapletalová J; Puchmayer V; Tvrzická E; Skorepa J
    Cas Lek Cesk; 1981 Feb; 120(7):189-93. PubMed ID: 7226186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
    Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rheologic aspects of the hematocrit and fibrinogen in evaluating rheographic measurements in patients with arteriosclerosis of the lower extremities].
    Dabrowski S; Lukjan H; Bielawiec M; Giedrojć J
    Kardiol Pol; 1986; 29(8):551-4. PubMed ID: 3560597
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum copper and zinc in rheumatoid arthritis and osteoarthritis.
    Grennan DM; Knudson JM; Dunckley J; MacKinnon MJ; Myers DB; Palmer DG
    N Z Med J; 1980 Jan; 91(652):47-50. PubMed ID: 6929437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
    Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
    Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentrations of calcium, magnesium, zinc and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men.
    Iskra M; Patelski J; Majewski W
    J Trace Elem Electrolytes Health Dis; 1993 Sep; 7(3):185-8. PubMed ID: 8155992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.